Adria Lab d.o.o.
Ljubljana, 1000, Slovenia
NCT Number: NCT03399240
This is a single site evaluation study of Vitastiq device accuracy in healthy men and women in ratio 1:1 (approximately) aged between 18 and 64 years. A total of 45 Vitastiq personal devices will be used by volunteers for two months. The Vitastiq device will be evaluated during three site visits: on day 1, 29 ± 4 days and 57 ± 4 days. During site visit days, blood sampling will be collected and analysed and readings using Vitastiq device will be performed. Data will be analysed retrospectively to evaluate Vitastiq performance compared to blood tests results.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Interventional
Not applicable
Ljubljana, 1000, Slovenia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant uses Vitastiq device for about 2 months to perform Vitastiq readings every day, preferably in the morning. On day 1, 29 and 57 participants' blood sampling is collected and analysed, and measurements using Vitastiq device are performed.
Time frame: 30 minutes
Vitastiq accuracy performance is at least 70% meaning that at least 70% of Vitastiq readings for each mineral and vitamin fall within the range of matching blood test results.
Time frame: 30 minutes
Vitastiq readings method is at least 80% repeatable. It means that at least 80% of Vitastiq readings for each mineral and vitamin performed by investigators and participant in the time frame of 30 minutes are comparable.
Vitastiq d.o.o.
Industry
Acronym: VITASTIQ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04659850
no Conditions
Aberdeen, Scotland, United Kingdom
View Trial DetailsNCT05042518
no Conditions
Salaya, Nakhonprathom, Thailand
View Trial DetailsNCT05628753
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Saskatoon, Saskatchewan, Canada
View Trial DetailsNCT05182138
no Conditions
Aberdeen, United Kingdom
View Trial Details